Impact of COVID-19 Outbreak on Erythropoietin (EPO) Drugs, Global Market Research Report 2020

June 2020 | 93 pages | ID: I2F658C717A8EN
QYResearch

Abstracts

The global Erythropoietin (EPO) Drugs market is valued at US$ 8482.1 million in 2020 is expected to reach US$ 12630 million by the end of 2026, growing at a CAGR of 5.8% during 2021-2026.
This report focuses on Erythropoietin (EPO) Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Erythropoietin (EPO) Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Erythropoietin (EPO) Drugs market is segmented into

• Epoetin-alfa
• Darbepoetin-alfa
• Epoetin-beta
• Others

Segment by Application

• Anemia
• Kidney Disorders
• Other

Global Erythropoietin (EPO) Drugs Market: Regional Analysis
The Erythropoietin (EPO) Drugs market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Erythropoietin (EPO) Drugs market report are:
North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Russia

Asia-Pacific

• China
• Japan
• South Korea
• India
• Australia
• Taiwan
• Indonesia
• Thailand
• Malaysia
• Philippines
• Vietnam

Latin America

• Mexico
• Brazil
• Argentina

Middle East & Africa

• Turkey
• Saudi Arabia
• U.A.E

Global Erythropoietin (EPO) Drugs Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Erythropoietin (EPO) Drugs market include:

• Amgen
• Johnson & Johnson
• Roche
• Galenica
• Emcure
• Kyowa Hakko Kirin
• 3SBio
• Biocon
• LG Life Sciences

Contents

1 ERYTHROPOIETIN (EPO) DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Erythropoietin (EPO) Drugs
1.2 Erythropoietin (EPO) Drugs Segment by Type
  1.2.1 Global Erythropoietin (EPO) Drugs Sales Growth Rate Comparison by Type (2021-2026)
  1.2.2 Epoetin-alfa
  1.2.3 Darbepoetin-alfa
  1.2.4 Epoetin-beta
  1.2.5 Others
1.3 Erythropoietin (EPO) Drugs Segment by Application
  1.3.1 Erythropoietin (EPO) Drugs Sales Comparison by Application: 2020 VS 2026
  1.3.2 Anemia
  1.3.3 Kidney Disorders
  1.3.4 Other
1.4 Global Erythropoietin (EPO) Drugs Market Size Estimates and Forecasts
  1.4.1 Global Erythropoietin (EPO) Drugs Revenue 2015-2026
  1.4.2 Global Erythropoietin (EPO) Drugs Sales 2015-2026
  1.4.3 Erythropoietin (EPO) Drugs Market Size by Region: 2020 Versus 2026

2 GLOBAL ERYTHROPOIETIN (EPO) DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Erythropoietin (EPO) Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Erythropoietin (EPO) Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Erythropoietin (EPO) Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Erythropoietin (EPO) Drugs Manufacturing Sites, Area Served, Product Type
2.5 Erythropoietin (EPO) Drugs Market Competitive Situation and Trends
  2.5.1 Erythropoietin (EPO) Drugs Market Concentration Rate
  2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Erythropoietin (EPO) Drugs Players (Opinion Leaders)

3 ERYTHROPOIETIN (EPO) DRUGS RETROSPECTIVE MARKET SCENARIO BY REGION

3.1 Global Erythropoietin (EPO) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Erythropoietin (EPO) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Erythropoietin (EPO) Drugs Market Facts & Figures by Country
  3.3.1 North America Erythropoietin (EPO) Drugs Sales by Country
  3.3.2 North America Erythropoietin (EPO) Drugs Sales by Country
  3.3.3 U.S.
  3.3.4 Canada
3.4 Europe Erythropoietin (EPO) Drugs Market Facts & Figures by Country
  3.4.1 Europe Erythropoietin (EPO) Drugs Sales by Country
  3.4.2 Europe Erythropoietin (EPO) Drugs Sales by Country
  3.4.3 Germany
  3.4.4 France
  3.4.5 U.K.
  3.4.6 Italy
  3.4.7 Russia
3.5 Asia Pacific Erythropoietin (EPO) Drugs Market Facts & Figures by Region
  3.5.1 Asia Pacific Erythropoietin (EPO) Drugs Sales by Region
  3.5.2 Asia Pacific Erythropoietin (EPO) Drugs Sales by Region
  3.5.3 China
  3.5.4 Japan
  3.5.5 South Korea
  3.5.6 India
  3.5.7 Australia
  3.5.8 Taiwan
  3.5.9 Indonesia
  3.5.10 Thailand
  3.5.11 Malaysia
  3.5.12 Philippines
  3.5.13 Vietnam
3.6 Latin America Erythropoietin (EPO) Drugs Market Facts & Figures by Country
  3.6.1 Latin America Erythropoietin (EPO) Drugs Sales by Country
  3.6.2 Latin America Erythropoietin (EPO) Drugs Sales by Country
  3.6.3 Mexico
  3.6.3 Brazil
  3.6.3 Argentina
3.7 Middle East and Africa Erythropoietin (EPO) Drugs Market Facts & Figures by Country
  3.7.1 Middle East and Africa Erythropoietin (EPO) Drugs Sales by Country
  3.7.2 Middle East and Africa Erythropoietin (EPO) Drugs Sales by Country
  3.7.3 Turkey
  3.7.4 Saudi Arabia
  3.7.5 U.A.E

4 GLOBAL ERYTHROPOIETIN (EPO) DRUGS HISTORIC MARKET ANALYSIS BY TYPE

4.1 Global Erythropoietin (EPO) Drugs Sales Market Share by Type (2015-2020)
4.2 Global Erythropoietin (EPO) Drugs Revenue Market Share by Type (2015-2020)
4.3 Global Erythropoietin (EPO) Drugs Price Market Share by Type (2015-2020)
4.4 Global Erythropoietin (EPO) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 GLOBAL ERYTHROPOIETIN (EPO) DRUGS HISTORIC MARKET ANALYSIS BY APPLICATION

5.1 Global Erythropoietin (EPO) Drugs Sales Market Share by Application (2015-2020)
5.2 Global Erythropoietin (EPO) Drugs Revenue Market Share by Application (2015-2020)
5.3 Global Erythropoietin (EPO) Drugs Price by Application (2015-2020)

6 COMPANY PROFILES AND KEY FIGURES IN ERYTHROPOIETIN (EPO) DRUGS BUSINESS

6.1 Amgen
  6.1.1 Corporation Information
  6.1.2 Amgen Description, Business Overview and Total Revenue
  6.1.3 Amgen Erythropoietin (EPO) Drugs Sales, Revenue and Gross Margin (2015-2020)
  6.1.4 Amgen Products Offered
  6.1.5 Amgen Recent Development
6.2 Johnson & Johnson
  6.2.1 Johnson & Johnson Erythropoietin (EPO) Drugs Production Sites and Area Served
  6.2.2 Johnson & Johnson Description, Business Overview and Total Revenue
  6.2.3 Johnson & Johnson Erythropoietin (EPO) Drugs Sales, Revenue and Gross Margin (2015-2020)
  6.2.4 Johnson & Johnson Products Offered
  6.2.5 Johnson & Johnson Recent Development
6.3 Roche
  6.3.1 Roche Erythropoietin (EPO) Drugs Production Sites and Area Served
  6.3.2 Roche Description, Business Overview and Total Revenue
  6.3.3 Roche Erythropoietin (EPO) Drugs Sales, Revenue and Gross Margin (2015-2020)
  6.3.4 Roche Products Offered
  6.3.5 Roche Recent Development
6.4 Galenica
  6.4.1 Galenica Erythropoietin (EPO) Drugs Production Sites and Area Served
  6.4.2 Galenica Description, Business Overview and Total Revenue
  6.4.3 Galenica Erythropoietin (EPO) Drugs Sales, Revenue and Gross Margin (2015-2020)
  6.4.4 Galenica Products Offered
  6.4.5 Galenica Recent Development
6.5 Emcure
  6.5.1 Emcure Erythropoietin (EPO) Drugs Production Sites and Area Served
  6.5.2 Emcure Description, Business Overview and Total Revenue
  6.5.3 Emcure Erythropoietin (EPO) Drugs Sales, Revenue and Gross Margin (2015-2020)
  6.5.4 Emcure Products Offered
  6.5.5 Emcure Recent Development
6.6 Kyowa Hakko Kirin
  6.6.1 Kyowa Hakko Kirin Erythropoietin (EPO) Drugs Production Sites and Area Served
  6.6.2 Kyowa Hakko Kirin Description, Business Overview and Total Revenue
  6.6.3 Kyowa Hakko Kirin Erythropoietin (EPO) Drugs Sales, Revenue and Gross Margin (2015-2020)
  6.6.4 Kyowa Hakko Kirin Products Offered
  6.6.5 Kyowa Hakko Kirin Recent Development
6.7 3SBio
  6.6.1 3SBio Erythropoietin (EPO) Drugs Production Sites and Area Served
  6.6.2 3SBio Description, Business Overview and Total Revenue
  6.6.3 3SBio Erythropoietin (EPO) Drugs Sales, Revenue and Gross Margin (2015-2020)
  6.4.4 3SBio Products Offered
  6.7.5 3SBio Recent Development
6.8 Biocon
  6.8.1 Biocon Erythropoietin (EPO) Drugs Production Sites and Area Served
  6.8.2 Biocon Description, Business Overview and Total Revenue
  6.8.3 Biocon Erythropoietin (EPO) Drugs Sales, Revenue and Gross Margin (2015-2020)
  6.8.4 Biocon Products Offered
  6.8.5 Biocon Recent Development
6.9 LG Life Sciences
  6.9.1 LG Life Sciences Erythropoietin (EPO) Drugs Production Sites and Area Served
  6.9.2 LG Life Sciences Description, Business Overview and Total Revenue
  6.9.3 LG Life Sciences Erythropoietin (EPO) Drugs Sales, Revenue and Gross Margin (2015-2020)
  6.9.4 LG Life Sciences Products Offered
  6.9.5 LG Life Sciences Recent Development

7 ERYTHROPOIETIN (EPO) DRUGS MANUFACTURING COST ANALYSIS

7.1 Erythropoietin (EPO) Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Key Raw Materials Price Trend
  7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Erythropoietin (EPO) Drugs
7.4 Erythropoietin (EPO) Drugs Industrial Chain Analysis

8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS

8.1 Marketing Channel
8.2 Erythropoietin (EPO) Drugs Distributors List
8.3 Erythropoietin (EPO) Drugs Customers

9 MARKET DYNAMICS

9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 GLOBAL MARKET FORECAST

10.1 Global Erythropoietin (EPO) Drugs Market Estimates and Projections by Type
  10.1.1 Global Forecasted Sales of Erythropoietin (EPO) Drugs by Type (2021-2026)
  10.1.2 Global Forecasted Revenue of Erythropoietin (EPO) Drugs by Type (2021-2026)
10.2 Erythropoietin (EPO) Drugs Market Estimates and Projections by Application
  10.2.1 Global Forecasted Sales of Erythropoietin (EPO) Drugs by Application (2021-2026)
  10.2.2 Global Forecasted Revenue of Erythropoietin (EPO) Drugs by Application (2021-2026)
10.3 Erythropoietin (EPO) Drugs Market Estimates and Projections by Region
  10.3.1 Global Forecasted Sales of Erythropoietin (EPO) Drugs by Region (2021-2026)
  10.3.2 Global Forecasted Revenue of Erythropoietin (EPO) Drugs by Region (2021-2026)
10.4 North America Erythropoietin (EPO) Drugs Estimates and Projections (2021-2026)
10.5 Europe Erythropoietin (EPO) Drugs Estimates and Projections (2021-2026)
10.6 Asia Pacific Erythropoietin (EPO) Drugs Estimates and Projections (2021-2026)
10.7 Latin America Erythropoietin (EPO) Drugs Estimates and Projections (2021-2026)
10.8 Middle East and Africa Erythropoietin (EPO) Drugs Estimates and Projections (2021-2026)

11 RESEARCH FINDING AND CONCLUSION

12 METHODOLOGY AND DATA SOURCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Erythropoietin (EPO) Drugs Sales (K Pcs) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Erythropoietin (EPO) Drugs Sales (K Pcs) Comparison by Application: 2020 VS 2026
Table 3. Global Erythropoietin (EPO) Drugs Market Size by Type (K Pcs) (US$ Million) (2020 VS 2026)
Table 4. Global Key Erythropoietin (EPO) Drugs Manufacturers Covered in This Study
Table 5. Global Erythropoietin (EPO) Drugs Sales (K Pcs) by Manufacturers (2015-2020)
Table 6. Global Erythropoietin (EPO) Drugs Sales Share by Manufacturers (2015-2020)
Table 7. Global Erythropoietin (EPO) Drugs Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Erythropoietin (EPO) Drugs Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Erythropoietin (EPO) Drugs Average Price (USD/Pcs) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Erythropoietin (EPO) Drugs Sales Sites and Area Served
Table 11. Manufacturers Erythropoietin (EPO) Drugs Product Types
Table 12. Global Erythropoietin (EPO) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Erythropoietin (EPO) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erythropoietin (EPO) Drugs as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Erythropoietin (EPO) Drugs Players
Table 16. Global Erythropoietin (EPO) Drugs Sales (K Pcs) by Region (2015-2020)
Table 17. Global Erythropoietin (EPO) Drugs Sales Market Share by Region (2015-2020)
Table 18. Global Erythropoietin (EPO) Drugs Revenue (Million US$) by Region (2015-2020)
Table 19. Global Erythropoietin (EPO) Drugs Revenue Market Share by Region (2015-2020)
Table 20. North America Erythropoietin (EPO) Drugs Sales by Country (2015-2020) (K Pcs)
Table 21. North America Erythropoietin (EPO) Drugs Sales Market Share by Country (2015-2020)
Table 22. North America Erythropoietin (EPO) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Erythropoietin (EPO) Drugs Revenue Market Share by Country (2015-2020)
Table 24. Europe Erythropoietin (EPO) Drugs Sales by Country (2015-2020) (K Pcs)
Table 25. Europe Erythropoietin (EPO) Drugs Sales Market Share by Country (2015-2020)
Table 26. Europe Erythropoietin (EPO) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Erythropoietin (EPO) Drugs Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Erythropoietin (EPO) Drugs Sales by Region (2015-2020) (K Pcs)
Table 29. Asia Pacific Erythropoietin (EPO) Drugs Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Erythropoietin (EPO) Drugs Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Erythropoietin (EPO) Drugs Revenue Market Share by Region (2015-2020)
Table 32. Latin America Erythropoietin (EPO) Drugs Sales by Country (2015-2020) (K Pcs)
Table 33. Latin America Erythropoietin (EPO) Drugs Sales Market Share by Country (2015-2020)
Table 34. Latin America Erythropoietin (EPO) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Erythropoietin (EPO) Drugs Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Erythropoietin (EPO) Drugs Sales by Country (2015-2020) (K Pcs)
Table 37. Middle East and Africa Erythropoietin (EPO) Drugs Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Erythropoietin (EPO) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Erythropoietin (EPO) Drugs Revenue Market Share by Country (2015-2020)
Table 40. Global Erythropoietin (EPO) Drugs Sales (K Pcs) by Type (2015-2020)
Table 41. Global Erythropoietin (EPO) Drugs Sales Share by Type (2015-2020)
Table 42. Global Erythropoietin (EPO) Drugs Revenue (Million US$) by Type (2015-2020)
Table 43. Global Erythropoietin (EPO) Drugs Revenue Share by Type (2015-2020)
Table 44. Global Erythropoietin (EPO) Drugs Price (USD/Pcs) by Type (2015-2020)
Table 45. Global Erythropoietin (EPO) Drugs Sales (K Pcs) by Application (2015-2020)
Table 46. Global Erythropoietin (EPO) Drugs Sales Market Share by Application (2015-2020)
Table 47. Global Erythropoietin (EPO) Drugs Sales Growth Rate by Application (2015-2020)
Table 48. Amgen Erythropoietin (EPO) Drugs Corporation Information
Table 49. Amgen Description and Business Overview
Table 50. Amgen Erythropoietin (EPO) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 51. Amgen Main Product
Table 52. Amgen Recent Development
Table 53. Johnson & Johnson Erythropoietin (EPO) Drugs Corporation Information
Table 54. Johnson & Johnson Corporation Information
Table 55. Johnson & Johnson Erythropoietin (EPO) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 56. Johnson & Johnson Main Product
Table 57. Johnson & Johnson Recent Development
Table 58. Roche Erythropoietin (EPO) Drugs Corporation Information
Table 59. Roche Corporation Information
Table 60. Roche Erythropoietin (EPO) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 61. Roche Main Product
Table 62. Roche Recent Development
Table 63. Galenica Erythropoietin (EPO) Drugs Corporation Information
Table 64. Galenica Corporation Information
Table 65. Galenica Erythropoietin (EPO) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 66. Galenica Main Product
Table 67. Galenica Recent Development
Table 68. Emcure Erythropoietin (EPO) Drugs Corporation Information
Table 69. Emcure Corporation Information
Table 70. Emcure Erythropoietin (EPO) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 71. Emcure Main Product
Table 72. Emcure Recent Development
Table 73. Kyowa Hakko Kirin Erythropoietin (EPO) Drugs Corporation Information
Table 74. Kyowa Hakko Kirin Corporation Information
Table 75. Kyowa Hakko Kirin Erythropoietin (EPO) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Kyowa Hakko Kirin Main Product
Table 77. Kyowa Hakko Kirin Recent Development
Table 78. 3SBio Erythropoietin (EPO) Drugs Corporation Information
Table 79. 3SBio Corporation Information
Table 80. 3SBio Erythropoietin (EPO) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. 3SBio Main Product
Table 82. 3SBio Recent Development
Table 83. Biocon Erythropoietin (EPO) Drugs Corporation Information
Table 84. Biocon Corporation Information
Table 85. Biocon Erythropoietin (EPO) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Biocon Main Product
Table 87. Biocon Recent Development
Table 88. LG Life Sciences Erythropoietin (EPO) Drugs Corporation Information
Table 89. LG Life Sciences Corporation Information
Table 90. LG Life Sciences Erythropoietin (EPO) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. LG Life Sciences Main Product
Table 92. LG Life Sciences Recent Development
Table 93. Sales Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Erythropoietin (EPO) Drugs Distributors List
Table 96. Erythropoietin (EPO) Drugs Customers List
Table 97. Market Key Trends
Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 99. Key Challenges
Table 100. Global Erythropoietin (EPO) Drugs Sales (K Pcs) Forecast by Type (2021-2026)
Table 101. Global Erythropoietin (EPO) Drugs Sales Market Share Forecast by Type (2021-2026)
Table 102. Global Erythropoietin (EPO) Drugs Revenue (Million US$) Forecast by Type (2021-2026)
Table 103. Global Erythropoietin (EPO) Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 104. Global Erythropoietin (EPO) Drugs Sales (K Pcs) Forecast by Application (2021-2026)
Table 105. Global Erythropoietin (EPO) Drugs Revenue (Million US$) Forecast by Application (2021-2026)
Table 106. Global Erythropoietin (EPO) Drugs Sales (K Pcs) Forecast by Region (2021-2026)
Table 107. Global Erythropoietin (EPO) Drugs Sales Market Share Forecast by Region (2021-2026)
Table 108. Global Erythropoietin (EPO) Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Global Erythropoietin (EPO) Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Erythropoietin (EPO) Drugs
Figure 2. Global Erythropoietin (EPO) Drugs Sales Market Share by Type: 2020 VS 2026
Figure 3. Epoetin-alfa Product Picture
Figure 4. Darbepoetin-alfa Product Picture
Figure 5. Epoetin-beta Product Picture
Figure 6. Others Product Picture
Figure 7. Global Erythropoietin (EPO) Drugs Consumption Market Share by Application: 2020 VS 2026
Figure 8. Anemia
Figure 9. Kidney Disorders
Figure 10. Other
Figure 11. Global Erythropoietin (EPO) Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Erythropoietin (EPO) Drugs Sales Capacity (K Pcs) (2015-2026)
Figure 13. Global Erythropoietin (EPO) Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Erythropoietin (EPO) Drugs Sales Share by Manufacturers in 2020
Figure 15. Global Erythropoietin (EPO) Drugs Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Erythropoietin (EPO) Drugs Revenue in 2019
Figure 17. Erythropoietin (EPO) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Erythropoietin (EPO) Drugs Sales Market Share by Region (2015-2020)
Figure 19. Global Erythropoietin (EPO) Drugs Sales Market Share by Region in 2019
Figure 20. Global Erythropoietin (EPO) Drugs Revenue Market Share by Region (2015-2020)
Figure 21. Global Erythropoietin (EPO) Drugs Revenue Market Share by Region in 2019
Figure 22. North America Erythropoietin (EPO) Drugs Sales Market Share by Country in 2019
Figure 23. North America Erythropoietin (EPO) Drugs Revenue Market Share by Country in 2019
Figure 24. U.S. Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 25. U.S. Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 27. Canada Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Erythropoietin (EPO) Drugs Sales Market Share by Country in 2019
Figure 29. Europe Erythropoietin (EPO) Drugs Revenue Market Share by Country in 2019
Figure 30. Germany Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 31. Germany Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 33. France Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 35. U.K. Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. Italy Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Russia Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Erythropoietin (EPO) Drugs Sales Market Share by Region in 2019
Figure 41. Asia Pacific Erythropoietin (EPO) Drugs Revenue Market Share by Region in 2019
Figure 42. China Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 43. China Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. Japan Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. South Korea Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. India Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Australia Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Taiwan Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Indonesia Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Thailand Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. Malaysia Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. Philippines Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Vietnam Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Erythropoietin (EPO) Drugs Sales Market Share by Country in 2019
Figure 65. Latin America Erythropoietin (EPO) Drugs Revenue Market Share by Country in 2019
Figure 66. Mexico Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Mexico Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Brazil Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Argentina Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Erythropoietin (EPO) Drugs Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Erythropoietin (EPO) Drugs Revenue Market Share by Country in 2019
Figure 74. Turkey Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Turkey Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Saudi Arabia Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. U.A.E Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. U.A.E Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Erythropoietin (EPO) Drugs by Type (2015-2020)
Figure 81. Sales Market Share of Erythropoietin (EPO) Drugs by Type in 2019
Figure 82. Revenue Share of Erythropoietin (EPO) Drugs by Type (2015-2020)
Figure 83. Revenue Market Share of Erythropoietin (EPO) Drugs by Type in 2019
Figure 84. Global Erythropoietin (EPO) Drugs Sales Growth by Type (2015-2020) (K Pcs)
Figure 85. Global Erythropoietin (EPO) Drugs Sales Market Share by Application (2015-2020)
Figure 86. Global Erythropoietin (EPO) Drugs Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Erythropoietin (EPO) Drugs by Application (2015-2020)
Figure 88. Global Revenue Share of Erythropoietin (EPO) Drugs by Application in 2020
Figure 89. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Galenica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Emcure Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Kyowa Hakko Kirin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. 3SBio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. LG Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Price Trend of Key Raw Materials
Figure 99. Manufacturing Cost Structure of Erythropoietin (EPO) Drugs
Figure 100. Manufacturing Process Analysis of Erythropoietin (EPO) Drugs
Figure 101. Erythropoietin (EPO) Drugs Industrial Chain Analysis
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. North America Erythropoietin (EPO) Drugs Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 106. North America Erythropoietin (EPO) Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Erythropoietin (EPO) Drugs Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Erythropoietin (EPO) Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Erythropoietin (EPO) Drugs Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Erythropoietin (EPO) Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Erythropoietin (EPO) Drugs Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Erythropoietin (EPO) Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Erythropoietin (EPO) Drugs Sales (K Pcs) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Erythropoietin (EPO) Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed